Competing mortality in patients diagnosed with bladder cancer: Evidence of undertreatment in the elderly and female patients

British Journal of Cancer

Volumn 108, Issue 7, 2013, Pages 1534-1540

  Noon, A P ^a   Albertsen, P C ^a   Thomas, F ^a   Rosario, D J ^a   Catto, J W F ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SPECIFIC MORTALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OTHER CAUSE MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84876492153     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.106     Document Type: Article

References (25)

1. Catto JW, Miah S, Owen HC, Bryant H, Myers K, Dudziec E, Larre S, Milo M, Rehman I, Rosario DJ, Di Martino E, Knowles MA, Meuth M, Harris AL, Hamdy FC (2009) Distinct microRNA alterations characterize high-and low-grade bladder cancer. Cancer Res 69(21): 8472-8481.
2. del Rey J, Placer J, Vallmanya F, Pujol N, Prat E, Miro R, Gelabert A (2010) Are patients with non-muscle-invasive bladder cancer a suitable population for a lung cancer screening trial? BJU Int 106(1): 49-52.
3. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7): 737-745.
4. Gray R (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist 16(3): 1141-1154.
5. Inman BA, Tran VT, Fradet Y, Lacombe L (2009) Carcinoma of the upper urinary tract: predictors of survival and competing causes of mortality. Cancer 115(13): 2853-2862.
6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. Cancer J Clinicians 61(2): 69-90.
7. Johnson EK, Daignault S, Zhang Y, Lee CT (2008) Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 72(3): 498-502; discussion 502-3.
8. Linton KD, Rosario DJ, Thomas F, Rubin N, Goepel JR, Abbod MF, Catto JW (2012) Disease specific mortality in patients with low risk bladder cancer and the impact of cystoscopic surveillance. J Urol 189(3): 828-833.
9. Lughezzani G, Sun M, Shariat SF, Budaus L, Thuret R, Jeldres C, Liberman D, Montorsi F, Perrotte P, Karakiewicz PI (2011) A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer. Cancer 117(1): 103-109.
10. Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche HM (2012) Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 62(4): 662-670.
11. Messing EM, Madeb R, Feng C, Stephenson L, Gilchrist KW, Young T, Gee J (2009) Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their disease. J Clin Oncol 27(15): 2443-2449.
12. Moore KT (1995) Establishing a new department of urology: an integrated system for national health service and private care. Br J Urol 76(6): 683-685.
13. Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55(6): 876-880. (Pubitemid 30330791)
14. Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, Bastian PJ, Vazina A, Gupta A, Lerner SP, Sagalowsky AI, Schoenberg MP, Palapattu GS (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51(3): 699-706; discussion 706-8.
15. Noon AP, Pickvance SM, Catto JW (2012) Occupational exposure to crack detection dye penetrants and the potential for bladder cancer. Occup Environ Med 69(4): 300-301.
16. Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Hofner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Muller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M (2012) Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med 9(6): 481-489.
17. Palou J, Sylvester RJ, Faba OR, Parada R, Pena JA, Algaba F, Villavicencio H (2012) Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guerin. Eur Urol 62(1): 118-125.
18. Rink M, Fajkovic H, Cha EK, Gupta A, Karakiewicz PI, Chun FK, Lotan Y, Shariat SF (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61(4): 854-855.
19. Scrucca L, Santucci A, Aversa F (2007) Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 40(4): 381-387. (Pubitemid 47202424)
20. Sheffield City Council (2012) Population Estimates, http://www.sheffield. gov.uk/your-city-council/sheffield-profile/population-and-health/ population-estimates.html, accessed 6 April 2012.
21. Sturgeon SR, Hartge P, Silverman DT, Kantor AF, Linehan WM, Lynch C, Hoover RN (1994) Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 5(2): 218-225. (Pubitemid 24073396)
22. Thomas F, Noon AP, Rubin N, Goepel JR, Catto JW (2013) Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer. Eur Urol 63(1): 145-154.
23. Thomas F, Rosario DJ, Rubin N, Goepel JR, Abbod MF, Catto JW (2012) The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: time to change treatment paradigm? Cancer 118(22): 5525-5534.
24. Walters S, Rachet B, Westlake S (2009) Cancer Survival, England, Patients Diagnosed 2001-2006 and Followed Up To 2007: One-Year and Five-Year Survival for 21 Common Cancers, by Sex and Age. Office for National Statistics: London, UK.
25. Youssef RF, Lotan Y (2011) Predictors of outcome of non-muscle-invasive and muscle-invasive bladder cancer. Scientific World J 11: 369-381.